User login
Article Type
Changed
Tue, 12/13/2016 - 12:08
Display Headline
Better Treatment Needed for Pulmonary Arterial Hypertension
Article PDF
Issue
Federal Practitioner - 27(5)
Publications
Page Number
E2
Legacy Keywords
treatment, pulmonary, pulmonary arterial hypertension, PAH, epoprostenol, EPO, prostacyclin analogues, PCA, endothelin receptor antagonists, phosphodiesterase-type-5 inhibitors, pulmonary arterial pressure, PAPtreatment, pulmonary, pulmonary arterial hypertension, PAH, epoprostenol, EPO, prostacyclin analogues, PCA, endothelin receptor antagonists, phosphodiesterase-type-5 inhibitors, pulmonary arterial pressure, PAP
Sections
Article PDF
Article PDF
Issue
Federal Practitioner - 27(5)
Issue
Federal Practitioner - 27(5)
Page Number
E2
Page Number
E2
Publications
Publications
Article Type
Display Headline
Better Treatment Needed for Pulmonary Arterial Hypertension
Display Headline
Better Treatment Needed for Pulmonary Arterial Hypertension
Legacy Keywords
treatment, pulmonary, pulmonary arterial hypertension, PAH, epoprostenol, EPO, prostacyclin analogues, PCA, endothelin receptor antagonists, phosphodiesterase-type-5 inhibitors, pulmonary arterial pressure, PAPtreatment, pulmonary, pulmonary arterial hypertension, PAH, epoprostenol, EPO, prostacyclin analogues, PCA, endothelin receptor antagonists, phosphodiesterase-type-5 inhibitors, pulmonary arterial pressure, PAP
Legacy Keywords
treatment, pulmonary, pulmonary arterial hypertension, PAH, epoprostenol, EPO, prostacyclin analogues, PCA, endothelin receptor antagonists, phosphodiesterase-type-5 inhibitors, pulmonary arterial pressure, PAPtreatment, pulmonary, pulmonary arterial hypertension, PAH, epoprostenol, EPO, prostacyclin analogues, PCA, endothelin receptor antagonists, phosphodiesterase-type-5 inhibitors, pulmonary arterial pressure, PAP
Sections
Article Source
PURLs Copyright
Inside the Article
Article PDF Media
Document